$XBI $153.10 +2% 📈
Want to access our searchable database of catalysts and more? Get access to BiopharmIQ for 30 days free, no credit card required. Check it out here!
$MRNA +8% (AH) Shipped variant-specific vaccine candidate, mRNA-1273.351 to NIH for clinical study. source
$KURA -12% Tipifarnib received FDA Breakthrough Therapy designation. source
$VSTM +7% Presents poster at the RAS-Targeted Drug Discovery Summit on its RAF/MEK inhibitor VS-6766. source
$SLDB -5% Will present 1-year efficacy and safety data for SGT-001 ongoing ph 1/2 IGNITE study on 3/18/21 at MDA conference. source
$ADMS -8% Proposed offering. source
$IFRX -9% Proposed offering.